Helene Tran
Director, Head of Antisense Oligonucleotide Therapeutic Program Servier
Seminars
Saturday 17th January 2026
Leveraging CNS PK & Biodistribution to Inform ASO Dosing
11:30 am
- Interpreting CNS exposure and tissue distribution across species
- Translating preclinical PK into human dose and dosing frequency
- Balancing effective target engagement with safety margins
